Why are PSIG's expenses fluctuating quarterly?

Paysign, Inc. (PSIG) is experiencing fluctuations in its quarterly expenses, which can be attributed to several factors: 1. **Revenue Growth**: PSIG's total revenues have shown an increase of 23.5% for the full year 2024, reaching $58.38 million. This growth in revenue can lead to fluctuations in expenses as the company adjusts its cost structure to accommodate the increased business activity. 2. **EBITDA Increase**: The company's EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization) has risen by $3.16 million, or 81.8%, to $7.02 million. This significant increase in EBITDA suggests that PSIG is managing its expenses effectively to support its growing revenue base. 3. **Adjusted EBITDA Improvement**: The Adjusted EBITDA, which is a non-GAAP metric, has also seen a notable improvement, increasing by 43.3% to $9.62 million. This indicates that PSIG is not only growing its top line but is also enhancing its operational efficiency, which can lead to better expense management. 4. **Plasma Center Expansion**: The addition of 33 net patient affordability programs and an increase in plasma center count have contributed to a significant increase in pharma revenue and patient affordability revenue. These strategic expansions can lead to both opportunities and challenges in managing expenses, as the company invests in new initiatives and scales up its operations. In conclusion, PSIG's fluctuating quarterly expenses are likely a result of the company's strategic responses to revenue growth, including adjustments in cost management and investment in expansion initiatives.